News for 'Sun Pharmaceuticals'

Amid Covid surge, govt approves ramping up remdesivir production

Amid Covid surge, govt approves ramping up remdesivir production

Rediff.com14 Apr 2021

The current total installed capacity of the seven manufacturers of remdesivir is 38.80 lakh vials per month, the Ministry of Chemicals and Fertilizers said in a statement.

Exports rise; trade deficit widens in Jan

Exports rise; trade deficit widens in Jan

Rediff.com1 Feb 2022

The country's exports rose by 23.69 per cent to $34.06 billion in January on healthy performance by engineering, petroleum and gems and jewellery segments even as trade deficit widened to $17.94 billion during the month, according to provisional data of the commerce ministry. Imports in January grew by 23.74 per cent to $52.01 billion, the data, released on Tuesday, showed. Trade deficit widened to $17.94 billion during the month as against $14.49 billion in the same month last year.

India's Russian imports up 3.5 times on oil buys despite Western pressure

India's Russian imports up 3.5 times on oil buys despite Western pressure

Rediff.com22 Jun 2022

On the back of rising crude oil purchases, India's bill for imports from sanctions-hit Russia jumped 3.5 times in a year in April to $2.3 billion, showed data from the commerce ministry. In April, India's crude oil imports from Russia were valued at $1.3 billion, 57 per cent of India's total inbound shipments from Russia. Other major imported items during the month included coal, soybean and sunflower oil, fertilisers, and non-industrial diamonds. That month, Russia was also the fourth-largest crude petroleum supplier to India, after Iraq, Saudi Arabia, and the United Arab Emirates (UAE).

How Shark Tank India 1 Winners Fared

How Shark Tank India 1 Winners Fared

Rediff.com14 Jan 2023

Of the 23 companies, eight have raised funds after Shark Tank India.

Coronavirus scare: India may soon run short of antibiotics, diabetes drugs

Coronavirus scare: India may soon run short of antibiotics, diabetes drugs

Rediff.com12 Feb 2020

Indian pharmaceutical companies are heavily dependent on China to source fermentation-based active pharmaceutical ingredients and intermediates to manufacture these medicines, but the coronavirus outbreak there has disrupted the supply.

11 pm to 5 am Covid-19 curfew in Delhi from today

11 pm to 5 am Covid-19 curfew in Delhi from today

Rediff.com27 Dec 2021

Patients and pregnant women, people out to buy essential items, and those travelling to or from railway stations, bus stops and airports will be exempted from the night curfew that kicks in at 11 pm on Monday due to rising COVID-19 cases in Delhi, according to a DDMA order.

Why Doctors Stopped Being Gods

Why Doctors Stopped Being Gods

Rediff.com15 Sep 2022

I got to know that every referred case for angiography and angioplasty got a kickback of Rs 5,000 and Rs 15,000 respectively. Seeing this trend, doctors started paying referring doctors Rs 1 lakh in advance and adjusting it as and when patients came in. This menace slowly spread its tentacles all over the medical field, including radiological diagnostics and biochemistry laboratories. For every test ordered, 20 per cent of the bill was given back to the referring doctor. This led to doctors recommending unnecessary tests. The pharmaceutical companies also saw burgeoning business. Acclaimed doctors were given televisions sets, refrigerators, air conditioners and cars depending upon the prescriptions. General practitioners would prescribe unnecessary drugs, and were given returns in cash. A fascinating excerpt from Dr Upendra Kaul's When The Heart Speaks.

Lupin aims to enter Chinese market in the next one year

Lupin aims to enter Chinese market in the next one year

Rediff.com8 Feb 2021

Once a difficult market to crack, in recent years, China has relatively opened up its drug market, enacting reforms and speeding up approval time.

Pakistan flood death toll crosses 1,000-mark; countries step in with aid

Pakistan flood death toll crosses 1,000-mark; countries step in with aid

Rediff.com28 Aug 2022

Floods triggered by the torrential rain since June 14 have wreaked havoc, inundating a vast swathe of flat land in the south and southwest of the country.

Imports from Russia jump 33% to $1.1 bn in March

Imports from Russia jump 33% to $1.1 bn in March

Rediff.com9 May 2022

Shipments from Russia rose nearly 33 per cent to $1.1 billion in March from $831.17 million in the previous month, which was when the country mounted aggression on Ukraine and faced sanctions from Western nations, the data accessed by Business Standard shows. Growth in imports was largely on account of oil, people aware of the matter said. The Department of Commerce is learnt to have written to the Ministry of Petroleum and Natural Gas (MoPNG), seeking details of imports, including the payment mechanism, which India has not made public.

Infosys, L&T are top picks of most brokerages for Samvat 2078

Infosys, L&T are top picks of most brokerages for Samvat 2078

Rediff.com12 Nov 2021

Despite unprecedented levels of uncertainty in Samvat 2077, investors have little to complain about on the returns front. The BSE Sensex delivered returns of 38 per cent in this period, while the Nifty registered a return of over 40 per cent. As is the case in bull markets, companies in the small- and mid-capitalisation basket outperformed the benchmarks, with returns almost twice those of frontliners.

Merck to license oral Covid drug Molnupiravir to 5 Indian firms

Merck to license oral Covid drug Molnupiravir to 5 Indian firms

Rediff.com27 Apr 2021

Drug firm MSD has decided to enter into voluntary licensing agreements for investigational oral antiviral drug candidate 'Mmolnupiravir', which is being studied for the treatment of Covid-19, with Indian drug firms Sun Pharma, Cipla, Dr Reddy's, Emcure Pharma and Hetero Labs, its Indian arm said on Tuesday.

Human Review

Human Review

Rediff.com14 Jan 2022

Human presents an ugly truth -- that some people need to die a painful death in order to facilitate the process of finding a cure for deadly diseases, observes Utkarsh Mishra.

A COVID-19 Vaccine Snapshot

A COVID-19 Vaccine Snapshot

Rediff.com28 Apr 2021

Sputnik V is already approved in India and Sinovac is unlikely to come in as it does not meet the criteria.

Corporate air travel takes wing on economic revival

Corporate air travel takes wing on economic revival

Rediff.com15 Feb 2021

Online travel portals and airlines say the demand from companies is being led by essential services sectors like pharmaceutical, oil and gas, and power.

Health expenditure's share in GDP down

Health expenditure's share in GDP down

Rediff.com7 Dec 2021

The share of total health expenditure as part of the gross domestic product (GDP) went down to 3.3 per cent in 2017-18 from 3.8 per cent in the previous two years, according to the national health account data released on Monday by the health ministry. The share of government expenditure as part of total expenditure as well as GDP has gone up from from 3.78 per cent to 5.12 per cent between 2013-14 and 2017-18, which could also explain a decline seen in out of pocket expenditure in 2017-18. Health ministry also emphasised the increase in the government health expenditure as part of the total GDP from 1.15 per cent in 2013-14 to 1.35 per cent in 2017-18.

Bharat Biotech seeks emergency nod for use of Covaxin

Bharat Biotech seeks emergency nod for use of Covaxin

Rediff.com8 Dec 2020

Covaxin is being indigenously developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR).

'Indian market one-eyed king in the land of the blind in 2022'

'Indian market one-eyed king in the land of the blind in 2022'

Rediff.com23 Sep 2022

'We have relatively strong growth and a healthy corporate earnings cycle as positives, but a worrisome current account deficit and high inflation as challenges.'

SBI stops deals related to Russian entities under sanctions

SBI stops deals related to Russian entities under sanctions

Rediff.com3 Mar 2022

State Bank of India, the nation's largest lender, has stopped processing transactions of Russian entities that have been sanctioned by the West over Moscow's invasion of Ukraine, sources said. To effect this, SBI has issued a circular as it fears that any transaction with entities or sectors under sanction will invite sanction on it as well, sources said. No transactions involving entities, banks, ports or vessels appearing on a US, European Union or United Nations sanctions list would be processed irrespective of the currency of the transaction, they said. Payments due to such entities have to be processed by other mechanism rather than through the banking channel, sources added.

A Clown Takes on Covid

A Clown Takes on Covid

Rediff.com31 May 2021

As India wages a daily battle against the second wave of coronavirus cases, a Mumbai clown turns Covid Warrior.

20 central PSUs in pipeline for sale, 6 for shutdown

20 central PSUs in pipeline for sale, 6 for shutdown

Rediff.com14 Sep 2020

As many as 20 central public sector enterprises and their units are at various stages of strategic disinvestment, while six are being considered for closure or are under litigation, Minister of State for Finance Anurag Singh Thakur said on Monday.

Govt lifts export ban on anti-malarial drug HCQ

Govt lifts export ban on anti-malarial drug HCQ

Rediff.com18 Jun 2020

Indian Council of Medical Research had also recommended the use of hydroxychloroquine for treating healthcare workers handling suspected or confirmed coronavirus cases and also the asymptomatic household contacts of the lab-confirmed cases.

Sensex rallies 534 pts led by gains in index heavyweights

Sensex rallies 534 pts led by gains in index heavyweights

Rediff.com4 Oct 2021

NTPC was the top gainer in the Sensex pack, rising around 4 per cent, followed by Bajaj Finserv, SBI, Bajaj Finance, Tech Mahindra, Dr Reddy's and Tata Steel.

FTA: UK, India not working towards Diwali deadline

FTA: UK, India not working towards Diwali deadline

Rediff.com14 Oct 2022

The free trade agreement (FTA) talks with India are no longer working towards a Diwali deadline though negotiations are progressing well, UK Trade Secretary Kemi Badenoch has said as New Delhi expressed confidence on Friday of an "early date" for a mutually beneficial deal. "There are ongoing negotiations as we know on the FTA. There is interest on both sides to see if we can work towards a deal, an FTA, that is beneficial to both the countries at an early date," external affairs ministry spokesperson Arindam Bagchi told reporters in New Delhi. It came as External Affairs Minister S Jaishankar spoke to his UK counterpart, James Cleverly, and referenced the Roadmap 2030 bilateral agreement signed between Prime Minister Narendra Modi and former UK PM Boris Johnson in May last year, with no specific reference to the FTA.

Exports jump to $34.5 bn in Jan; trade deficit widens to $17.43 bn

Exports jump to $34.5 bn in Jan; trade deficit widens to $17.43 bn

Rediff.com15 Feb 2022

India's exports in January rose 25.28 per cent to $34.50 billion on account of healthy performance by mainly engineering, petroleum and gems and jewellery sectors, even as trade deficit widened to 17.43 billion, according to data released by the commerce ministry on Tuesday. Imports grew by 23.54 per cent to $51.93 billion during the month under review. Trade deficit, difference between imports and exports, stood at $14.50 bn in January 2021.

'Urban Naxals' trying to enter Gujarat: Modi targets AAP

'Urban Naxals' trying to enter Gujarat: Modi targets AAP

Rediff.com10 Oct 2022

The Arvind Kejriwal-led AAP is trying to make inroads into BJP-ruled Gujarat where the assembly polls are due later this year.

'Market rally more likely to sustain than come to grinding halt'

'Market rally more likely to sustain than come to grinding halt'

Rediff.com1 Oct 2021

'Private banks are well-placed to deliver good performance over the next six months.'

India's rich club grows to 1,103; Zepto's Kaivalya youngest in Hurun list

India's rich club grows to 1,103; Zepto's Kaivalya youngest in Hurun list

Rediff.com22 Sep 2022

One hundred and forty nine new individuals joined the rich list club of 1,103 Indians across 122 cities who cumulatively accumulated a wealth of Rs 100 trillion. Bengaluru -based Kaivalya Vohra, 19, of grocery delivery application Zepto is the youngest self-made and the youngest rich individual, according to IIFL Wealth Hurun India Rich List 2022. The report found 1,103 Indians with a networth of Rs 1,000 crore each - an increase of 62 per cent over five years. There are 221 billionaires (Rs 100 crore networth) in India on the 2022 list - down 16 compared with last year, while 13 people born in the 1990s made it to the list, all self-made.

Delhi will float global tender for Covid vaccine

Delhi will float global tender for Covid vaccine

Rediff.com11 May 2021

Earlier in the day, Delhi Chief Minister Arvind Kejriwal also wrote to Prime Minister Narendra Modi over vaccine shortage, saying the Centre should share the vaccine formula of the two manufacturers with other capable pharmaceutical companies to scale up production in the country.

Delhi weekend curfew: Who will be exempted

Delhi weekend curfew: Who will be exempted

Rediff.com5 Jan 2022

A list of who all will be exempted during weekend curfew imposed in Delhi from Friday 10 pm to Monday 5 am in view of surge in COVID-19 cases.

6 workers killed in fire in chemical factory in AP

6 workers killed in fire in chemical factory in AP

Rediff.com14 Apr 2022

More than 50 workers were at work in the night shift when the mishap occurred in unit-4.

Iran keen to relaunch rupee-rial trade for exporting oil

Iran keen to relaunch rupee-rial trade for exporting oil

Rediff.com19 Mar 2022

Iran has offered to help India meet its energy needs by relaunching rupee-rial trade for export of oil and gas, said Iranian ambassador to India Ali Chegeni. Chegeni said if both the countries resume rupee-rial trade, bilateral trade can touch $30 billion. Iran used to be India's second largest oil supplier but New Delhi had to halt imports after the former US president Donald Trump withdrew from the nuclear deal with Iran and re-imposed sanctions on its oil exports.

Russia reaches out to Kerala for Sputnik V plant

Russia reaches out to Kerala for Sputnik V plant

Rediff.com29 Jul 2021

The government may look at areas around Thonnakkal, in Thiruvananthapuram district, for the facility. If successful, this would be one of the few sites of Sputnik V owned by Russian firms outside that country. Shine Jacob and Sohini Das report.

33 of 95 BSE100 cos INCREASED CAPEX

33 of 95 BSE100 cos INCREASED CAPEX

Rediff.com4 Feb 2021

Acquisitions may have played a role in much of the increase.

Every 3rd tablet in the US market is from India

Every 3rd tablet in the US market is from India

Rediff.com9 Jul 2020

India lost its competitive advantage as China gave fiscal benefits to its local manufacturers. Besides, recent policy flip-flops have, however, dented India's image as the 'pharmacy of the world'.

MHA issues fresh guidelines on lockdown exemption

MHA issues fresh guidelines on lockdown exemption

Rediff.com25 Mar 2020

The guidelines listed several services including government and private offices that will be out of bounds during the period, while exempting establishments such as hospitals, ration shops, dairies, banks, insurance offices, and print and electronic media. Delivery of all essential goods including food, pharmaceuticals, medical equipment through e-commerce has also been exempted from the purview of the lockdown.

India's rising medical devices imports hurt small and medium units

India's rising medical devices imports hurt small and medium units

Rediff.com19 Jul 2022

India's medical devices imports surged 41 per cent to touch Rs 63,200 crore in 2021-22, led by a 48 per cent year-on-year (YoY) jump in imports from China to Rs 13,538 crore, the commerce ministry data analysed by the Association of Indian Medical Device Industry (AiMeD) has showed. Local industry players say this has led to several small and medium units to shut shop. Rakesh Vaid of Usha Fabs, a garments exporter, had started making N95 masks in his Gurgaon factory during the peak of the Covid-19 pandemic.

Hydroxychloroquine exports only to foreign govts, not pvt cos

Hydroxychloroquine exports only to foreign govts, not pvt cos

Rediff.com10 Apr 2020

India will export anti-malarial drug hydroxychloroquine, high in demand globally, only to foreign governments and not to private companies, as the product is under prohibited or banned category of exports, sources said. Although exports of this medicine is completely banned, India has decided to export this anti-malarial drug in sync with its global commitment to deal with the coronavirus pandemic.

Biological E plans to make 100m Corbevax jabs per month from Feb 2022

Biological E plans to make 100m Corbevax jabs per month from Feb 2022

Rediff.com28 Dec 2021

Biological E Limited plans to complete production at a rate of 75 million doses of its COVID-19 vaccine Corbevax per month, anticipating over 100 million doses per month from February 2022 which will enable the Hyderabad-based company to deliver 300 Million doses as promised to the Centre, BE said on Tuesday.

'Markets will be in consolidation mode for some time'

'Markets will be in consolidation mode for some time'

Rediff.com15 Jun 2022

'Investors need to expect steady returns over the next one to two years with bouts of high volatility.'